Free Trial

Moody's Investors Service commented "that...>

RATINGS
RATINGS: Moody's Investors Service commented "that a sale by US's Pfizer of its
Consumer Healthcare business would have positive implications for liquidity. The
company would have significant flexibility in choosing how to redeploy any such
asset sale proceeds." 
- Moody's said that "this would outweigh the relatively modest loss of earnings
and product diversification from the divested Consumer Healthcare business.
There is no impact on Pfizer's ratings including the A1 senior unsecured rating
or on the stable rating outlook."

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.